PATRICIA HALL: Open Payments
NPI 1194445221 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 40 payments from 14 companies in 2025. Trend: 2023 $765 · 2024 $1,648 · 2025 $1,037
Food & beverage: $992Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $338 |
| Janssen Biotech, Inc. | 2 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $119 |
| Amgen Inc. | 4 | $100 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Fresenius Kabi USA, LLC | 2 | $49 |
| Organon LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| GENZYME CORPORATION | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: RINVOQ, TREMFYA, SKYRIZI, BENLYSTA, HADLIMA, TAVNEOS, KEVZARA, EVENITY.
Industry payments across MA — which companies pay providers there.
